scholarly journals Neurodegeneration by α-synuclein-specific T cells in AAV-A53T-α-synuclein Parkinson’s disease mice

Author(s):  
Akua A. Karikari ◽  
Rhonda L. McFleder ◽  
Eliana Ribechini ◽  
Robert Blum ◽  
Valentin Bruttel ◽  
...  
2017 ◽  
Vol 16 (10) ◽  
pp. 769-771 ◽  
Author(s):  
R Lee Mosley ◽  
Howard E Gendelman

2019 ◽  
Vol 60 ◽  
pp. 25-31 ◽  
Author(s):  
Jill K. Baird ◽  
Dennis Bourdette ◽  
Charles K. Meshul ◽  
Joseph F. Quinn

1994 ◽  
Vol 121 (1) ◽  
pp. 39-45 ◽  
Author(s):  
Urszula Fiszer ◽  
Eilhard Mix ◽  
Sten Fredrikson ◽  
Vasilios Kostulas ◽  
Tomas Olsson ◽  
...  

2021 ◽  
Vol 18 (1) ◽  
Author(s):  
Divisha Bhatia ◽  
Veselin Grozdanov ◽  
Wolfgang P. Ruf ◽  
Jan Kassubek ◽  
Albert C. Ludolph ◽  
...  

AbstractThe dysregulation of peripheral immunity in Parkinson’s Disease (PD) includes changes in both the relative numbers and gene expression of T cells. The presence of peripheral T-cell abnormalities in PD is well-documented, but less is known about their association to clinical parameters, such as age, age of onset, progression rate or severity of the disease. We took a detailed look at T-cell numbers, gene expression and activation in cross-sectional cohorts of PD patients and age-matched healthy controls by means of flow cytometry and NanoString gene expression assay. We show that the well-pronounced decrease in relative T-cell numbers in PD blood is mostly driven by a decrease of CD8+ cytotoxic T cells and is primarily associated with the severity of the disease. In addition, we demonstrate that the expression of inflammatory genes in T cells from PD patients is also associated with disease severity. PD T cells presented with increased activation upon stimulation with phytohemagglutinin that also correlated with disease severity. In summary, our data suggest that the consequences of disease severity account for the changes in PD T cells, rather than age, age of onset, duration or the disease progression rate.


2020 ◽  
Author(s):  
Xiuzhen Zhao ◽  
Tao Jin ◽  
Chao Zheng ◽  
Di Ma ◽  
Ying Zhang

Abstract Background: Follicular helper T (Tfh) cells and follicular regulatory T (Tfr) cells are essential for B cell differentiation, germinal center formation, and humoral immune responses. Immunity and inflammation have been thought to be involved in Parkinson’s disease (PD). In this study, we aimed to identify whether circulating Tfh and Tfr (cTfh and cTfr) cells contribute to PD.Methods: Thirty-nine PD patients and 26 health controls (HCs) were enrolled. The numbers of cTfh (CD4+CXCR5+PD-1+) cells and cTfr (CD4+CXCR5+CD25hiCD127low) cells were analyzed via flow cytometry. The serum concentrations of interleukin (IL)-4, IL-10, IL-21, and transforming growth factor (TGF)-β were examined by cytometric bead array.Results: The percentage of cTfh cells among CD4+ T cells in PD patients was significantly higher than that in HCs [3.68% (2.64%–5.70%) vs 1.94% (1.32%–2.99%), P<0.001], while the percentage of cTfr cells among CD4+ T cells in PD patients was slight decreased but without significance [1.05% (0.62%–1.54%) vs 1.3% (0.63%–1.90%), P>0.05]. The percentage of CD19+ B cells in peripheral blood mononuclear cells was significantly lower in PD patients than in HCs [5.35% (4.13%–9.38%) vs 8.68% (5.61%–12.93%), P=0.014]. The serum concentrations of IL-4, IL-10, IL-21, and TGF-β in PD patients did not differ significantly from those in HCs (P>0.05). However, significant positive correlations were found for the serum concentration of IL-21 with H-Y stage (r=0.356, P=0.026) and UPDRS-III score (r=0.347, P=0.030).Conclusions: These results indicate that an imbalance of cTfh and cTfr cells may be involved in the chronic progression of PD, and IL-21 may be a biomarker for monitoring the severity of this disease.


Nature ◽  
2017 ◽  
Vol 549 (7671) ◽  
pp. 292-292 ◽  
Author(s):  
David Sulzer ◽  
Roy N. Alcalay ◽  
Francesca Garretti ◽  
Lucien Cote ◽  
Ellen Kanter ◽  
...  

2020 ◽  
Vol 12 (544) ◽  
pp. eabb7100
Author(s):  
Albert A. Davis

Analysis of peripheral blood mononuclear cells demonstrated that α-synuclein–specific T cells are active in preclinical and early Parkinson’s disease.


Sign in / Sign up

Export Citation Format

Share Document